Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate

FDA Drug Profile — Uretron D/S

Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Uretron D/S. Available dosage form: tablet.

Drug details

Generic Name
Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
Brand Names
Uretron D/S
Sponsor
DORAL PHARMAMEDICS INC Dba A.G. Marin Pharmaceuticals
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, HYOSCYAMINE SULFATE, METHYLENE BLUE, METHENAMINE

Indications and Usage

INDICATIONS AND USAGE Uretron D/S tablets are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

Warnings

WARNINGS Do not exceed recommended dosage. If rapid pulse, dizziness or blurring of vision occurs discontinue use immediately.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.